SAN DIEGO, Feb. 1, 2016 /CNW/ -- Organovo Holdings, Inc. (NYSE MKT:ONVO) ("Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that Chairman and Chief Executive Officer Keith Murphy is scheduled to speak at VirtualInvestorConferences.com on Thursday, February 11, 2016 at 12:00 p.m. Eastern Time (ET).
For investors who are not yet familiar with the Company, an informational video and investor presentation is available on Organovo's website: http://www.organovo.com/
Date: Thursday, February 11, 2016
Time: 9:00 a.m. PT/12:00 p.m. ET
It is recommended that investors pre-register to save time and receive event updates. This will be a live, interactive online event where investors are invited to ask the company questions in real-time, both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
Learn more about the event at www.VirtualInvestorConferences.com.
About Organovo Holdings Inc.
Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The Company develops 3D human disease models through internal development and in collaboration with pharmaceutical and academic partners. Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. The Company recently launched its initial product of the planned exVive3DTM portfolio offering, the exVive3D Human Liver Tissue for use in toxicology and other preclinical drug testing. Additional products are in development, with the anticipated release of the exVive3D Human Kidney Tissue scheduled for the third quarter of calendar year 2016. The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous other media outlets. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform. Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Logo - http://photos.prnewswire.com/prnh/20160129/327291LOGO
SOURCE Organovo Holdings, Inc.
For further information: Investor Contact: Steve Kunszabo, Organovo Holdings, Inc., +1 (858) 224-1092, firstname.lastname@example.org; Press Contact: Jessica Yingling, Little Dog Communications, +1 (858) 480-2411, email@example.com, http://www.organovo.com